ijms-logo

Journal Browser

Journal Browser

Adipose Stem Cells 2023

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 4967

Special Issue Editor


E-Mail Website
Guest Editor
School of Medicine, Juntendo University, Tokyo 13-8421, Japan
Interests: stem cells; adipose tissue stem cells; polyplatelet plasma; regenerative medicine; proliferating factor

Special Issue Information

Dear Colleagues, 

In the early 2000s, the presence of MSCs in subcutaneous adipose tissue was reported, and cell therapy using adipose tissue stem cells have attracted attention as a practical regenerative medicine that is being studied worldwide. The ability to safely and easily collect tissue (subcutaneous fat), which is the raw material for transplanted cells, is extremely important for expanding the application of regenerative medicine, and it is believed that regenerative medicine using adipose tissue stem cells will become the center of autologous cell therapy in the future. In fact, numerous clinical trials have been conducted, and commercialized cell therapies are now available.

This Special Issue focuses on the practical application of adipose tissue stem cells and solicits a wide range of topics on the current status, issues, and future prospects of regenerative medicine using adipose tissue stem cells. We are planning a special feature consisting of clinical trials of regenerative medicine using adipose tissue stem cells in various fields and new findings on adipose stem cells.

Dr. Morikuni Tobita
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adipose tissue stem cells
  • clinical trials
  • regenerative medicine products
  • mesenchymal stem cells
  • regenerative medicine
  • practical application issues
 

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

10 pages, 2269 KiB  
Article
Conservation of Markers and Stemness in Adipose Stem and Progenitor Cells between Cattle and Other Species
by Yuki Ishida, Yo Mabuchi, Yuna Naraoka, Daisuke Hisamatsu and Chihiro Akazawa
Int. J. Mol. Sci. 2023, 24(15), 11908; https://doi.org/10.3390/ijms241511908 - 25 Jul 2023
Cited by 2 | Viewed by 1132
Abstract
Adipose stem and progenitor cells (ASPCs) have been isolated from humans and animals for use in regenerative medicine and therapy. However, knowledge of ASPCs in other species is limited. Particularly, ASPCs in livestock are expected to enhance the fat content and meat composition. [...] Read more.
Adipose stem and progenitor cells (ASPCs) have been isolated from humans and animals for use in regenerative medicine and therapy. However, knowledge of ASPCs in other species is limited. Particularly, ASPCs in livestock are expected to enhance the fat content and meat composition. In this study, we isolated bovine ASPCs using cell surface markers. Specifically, we focused on ASPC markers in humans and experimental animals, namely CD26, CD146, and CD54. Stromal vascular fraction cells from bovine fat were separated using flow cytometry before primary culture. We evaluated the self-renewal and adipogenic potential of each fraction. We identified four cell populations: CD26−CD146+CD54+, CD26−CD146+CD54−, CD26−CD146−, and CD26+CD146−. Among them, the CD26−CD146+ fraction, particularly CD54+, demonstrated the properties of preadipocytes (PreAs), characterized by slow proliferation and a high adipogenic capacity. In conclusion, we could collect and characterize possible PreAs as CD26−CD146+CD54+ or CD26−CD146+CD54−, which are expected for in vitro bovine adipogenic assays in the future. Full article
(This article belongs to the Special Issue Adipose Stem Cells 2023)
Show Figures

Figure 1

13 pages, 1851 KiB  
Article
Mechanical Stress Improves Fat Graft Survival by Promoting Adipose-Derived Stem Cells Proliferation
by Jeong Jin Chun, Jiyeon Chang, Shindy Soedono, Jieun Oh, Yeong Jin Kim, Syeo Young Wee, Kae Won Cho and Chang Yong Choi
Int. J. Mol. Sci. 2022, 23(19), 11839; https://doi.org/10.3390/ijms231911839 - 6 Oct 2022
Cited by 1 | Viewed by 2029
Abstract
Cell-assisted lipotransfer (CAL), defined as co-transplantation of aspirated fat with enrichment of adipose-derived stem cells (ASCs), is a novel technique for cosmetic and reconstructive surgery to overcome the low survival rate of traditional fat grafting. However, clinically approved techniques for increasing the potency [...] Read more.
Cell-assisted lipotransfer (CAL), defined as co-transplantation of aspirated fat with enrichment of adipose-derived stem cells (ASCs), is a novel technique for cosmetic and reconstructive surgery to overcome the low survival rate of traditional fat grafting. However, clinically approved techniques for increasing the potency of ASCs in CAL have not been developed yet. As a more clinically applicable method, we used mechanical stress to reinforce the potency of ASCs. Mechanical stress was applied to the inguinal fat pad by needling . Morphological and cellular changes in adipose tissues were examined by flow cytometric analysis 1, 3, 5, and 7 days after the procedure. The proliferation and adipogenesis potencies of ASCs were evaluated. CAL with ASCs treated with mechanical stress or sham control were performed, and engraftment was determined at 4 weeks post-operation. Flow cytometry analysis revealed that mechanical stress significantly increased the number as well as the frequency of ASC proliferation in fat. Proliferation assays and adipocyte-specific marker gene analysis revealed that mechanical stress promoted proliferation potential but did not affect the differentiation capacity of ASCs. Moreover, CAL with cells derived from mechanical stress-treated fat increased the engraftment. Our results indicate that mechanical stress may be a simple method for improving the efficacy of CAL by enhancing the proliferation potency of ASCs. Full article
(This article belongs to the Special Issue Adipose Stem Cells 2023)
Show Figures

Figure 1

Review

Jump to: Research

23 pages, 1668 KiB  
Review
Adipose Tissue in Breast Cancer Microphysiological Models to Capture Human Diversity in Preclinical Models
by Katie M. Hamel, Trivia P. Frazier, Christopher Williams, Tamika Duplessis, Brian G. Rowan, Jeffrey M. Gimble and Cecilia G. Sanchez
Int. J. Mol. Sci. 2024, 25(5), 2728; https://doi.org/10.3390/ijms25052728 - 27 Feb 2024
Viewed by 1177
Abstract
Female breast cancer accounts for 15.2% of all new cancer cases in the United States, with a continuing increase in incidence despite efforts to discover new targeted therapies. With an approximate failure rate of 85% for therapies in the early phases of clinical [...] Read more.
Female breast cancer accounts for 15.2% of all new cancer cases in the United States, with a continuing increase in incidence despite efforts to discover new targeted therapies. With an approximate failure rate of 85% for therapies in the early phases of clinical trials, there is a need for more translatable, new preclinical in vitro models that include cellular heterogeneity, extracellular matrix, and human-derived biomaterials. Specifically, adipose tissue and its resident cell populations have been identified as necessary attributes for current preclinical models. Adipose-derived stromal/stem cells (ASCs) and mature adipocytes are a normal part of the breast tissue composition and not only contribute to normal breast physiology but also play a significant role in breast cancer pathophysiology. Given the recognized pro-tumorigenic role of adipocytes in tumor progression, there remains a need to enhance the complexity of current models and account for the contribution of the components that exist within the adipose stromal environment to breast tumorigenesis. This review article captures the current landscape of preclinical breast cancer models with a focus on breast cancer microphysiological system (MPS) models and their counterpart patient-derived xenograft (PDX) models to capture patient diversity as they relate to adipose tissue. Full article
(This article belongs to the Special Issue Adipose Stem Cells 2023)
Show Figures

Figure 1

Back to TopTop